InfuSystem Holdings (INFU) Stock Overview
Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for INFU from our risk checks.
INFU Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
InfuSystem Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.28 |
| 52 Week High | US$11.04 |
| 52 Week Low | US$4.61 |
| Beta | 1.7 |
| 1 Month Change | -10.42% |
| 3 Month Change | -12.29% |
| 1 Year Change | 2.77% |
| 3 Year Change | 5.33% |
| 5 Year Change | -45.09% |
| Change since IPO | 73.13% |
Recent News & Updates
Shareholder Returns
| INFU | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -2.4% | 3.0% | 2.9% |
| 1Y | 2.8% | -21.2% | 12.5% |
Return vs Industry: INFU exceeded the US Healthcare industry which returned -21.3% over the past year.
Return vs Market: INFU underperformed the US Market which returned 12.6% over the past year.
Price Volatility
| INFU volatility | |
|---|---|
| INFU Average Weekly Movement | 6.4% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: INFU has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: INFU's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 508 | Carrie Lachance | www.infusystem.com |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
InfuSystem Holdings, Inc. Fundamentals Summary
| INFU fundamental statistics | |
|---|---|
| Market cap | US$188.72m |
| Earnings (TTM) | US$5.52m |
| Revenue (TTM) | US$141.05m |
Is INFU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INFU income statement (TTM) | |
|---|---|
| Revenue | US$141.05m |
| Cost of Revenue | US$62.98m |
| Gross Profit | US$78.08m |
| Other Expenses | US$72.55m |
| Earnings | US$5.52m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 55.35% |
| Net Profit Margin | 3.92% |
| Debt/Equity Ratio | 37.7% |
How did INFU perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/01 10:33 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
InfuSystem Holdings, Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyle Bauser | B. Riley Securities, Inc. |
| Anderson Schock | B. Riley Securities, Inc. |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |